We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Express Scripts Holding Company (delisted) | NASDAQ:ESRX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 92.33 | 92.35 | 92.56 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
By Josh Beckerman
A New York state regulator scheduled a Dec. 7 public hearing concerning Cigna Corp.'s (CI) purchase of Express Scripts Holding Co. (ESRX).
The cash-and-stock deal was valued at $54 billion when announced in March.
The Department of Financial Services said the meeting "will provide an opportunity for all stakeholders to comment on the potential impacts on consumers and the insurance marketplace."
As of Nov. 1, the deal had received 23 state approvals and needed six more.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
November 21, 2018 16:40 ET (21:40 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Express Scripts Holding Company (delisted) Chart |
1 Month Express Scripts Holding Company (delisted) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
